Another stock in the red, Alkermes (ALKS Quote) gave up 87 cents, or 6.4%, to $12.75 on Friday. The company said Thursday after the market close that it lost $18.3 million, or 19 cents a share, vs. a year-ago profit of $3.5 million, or 3 cents a share, a year ago. Revenue edged down to $64.2 million from $64.8 million.
Harmed by Eli Lilly's (LLY Quote) decision to end development of their partnered inhaled insulin product earlier this year, Alkermes also said it expects a loss in 2009. The company expects to lose between 11 and 16 cents a share, on revenue of $175 million to $200 million. Analysts surveyed by Thomson Reuters had pegged a profit of 20 cents a share on $245 million in revenue.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,400.39 | 1,107.01 | 2,195.41 | 34.59 |
Oil *
76.63
|
|
UP
11.49
|
UP
1.03
|
UP
1.06
|
DOWN
0.24
|
10 Yr
3.46%
SPDR Gold
113.75
|
|
+0.11%
|
+0.09%
|
+0.05%
|
-0.69%
|
Data delayed 20 minutes |














